GFRA3
GDNF family receptor alpha-3
Also known as: GFRa-3, GFRA3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O60609
- Gene
- GFRA3
- Ensembl
- ENSG00000146013
- Chromosome
- 5
- Canonical length
- 400 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a glycosylphosphatidylinositol(GPI)-linked cell surface receptor and a member of the GDNF receptor family. It forms a signaling receptor complex with RET tyrosine kinase receptor and binds the ligand, artemin. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
400 residues, UniProt reviewed canonical sequence.
>O60609|GFRA3
1 MVRPLNPRPL PPVVLMLLLL LPPSPLPLAA GDPLPTESRL MNSCLQARRK CQADPTCSAA
61 YHHLDSCTSS ISTPLPSEEP SVPADCLEAA QQLRNSSLIG CMCHRRMKNQ VACLDIYWTV
121 HRARSLGNYE LDVSPYEDTV TSKPWKMNLS KLNMLKPDSD LCLKFAMLCT LNDKCDRLRK
181 AYGEACSGPH CQRHVCLRQL LTFFEKAAEP HAQGLLLCPC APNDRGCGER RRNTIAPNCA
241 LPPVAPNCLE LRRLCFSDPL CRSRLVDFQT HCHPMDILGT CATEQSRCLR AYLGLIGTAM
301 TPNFVSNVNT SVALSCTCRG SGNLQEECEM LEGFFSHNPC LTEAIAAKMR FHSQLFSQDW
361 PHPTFAVMAH QNENPAVRPQ PWVPSLFSCT LPLILLLSLWLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GFRA3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- colon: 13 nTPM
- vagina: 7.1 nTPM
- cervix: 6.7 nTPM
- stomach: 6.3 nTPM
- heart muscle: 5.6 nTPM
- seminal vesicle: 5.5 nTPM
Single-cell type
- schwann cells: 75 nCPM
- neuroendocrine cells: 63 nCPM
- oocytes: 51 nCPM
- late spermatids: 35 nCPM
- differentiating spermatogonia: 8.2 nCPM
- early spermatids: 8.1 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 5.2 nTPM
- cerebral cortex: 0.6 nTPM
- pons: 0.5 nTPM
- hypothalamus: 0.4 nTPM
- basal ganglia: 0.3 nTPM
- spinal cord: 0.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.64
- gnomAD pLI
- 0.03
- gnomAD missense Z
- 2.05
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- glial cell-derived neurotrophic factor receptor signaling pathway
- nervous system development
- neuron migration
- peripheral nervous system development
- signal transduction
- sympathetic nervous system development
Molecular functions
- axon guidance receptor activity
- glial cell-derived neurotrophic factor receptor activity
- signaling receptor activity
- signaling receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Glial cell line-derived neurotrophic factor receptor
- GDNF/GAS1
- GDNF receptor alpha
- GDNF/GAS1 domain
- Glial cell line-derived neurotrophic factor receptor, alpha 3
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GFRA3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GFRA3 as an antibody target. Whether an autoantibody or antibody against GFRA3 could matter depends on whether native GFRA3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GFRA3 is annotated at the cell surface, where native GFRA3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GFRA3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...